208 related articles for article (PubMed ID: 37458037)
21. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
22. Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer's disease.
Burgaletto C; Platania CBM; Di Benedetto G; Munafò A; Giurdanella G; Federico C; Caltabiano R; Saccone S; Conti F; Bernardini R; Bucolo C; Cantarella G
Cell Death Dis; 2021 Oct; 12(10):905. PubMed ID: 34611142
[TBL] [Abstract][Full Text] [Related]
23. [Expression profile of miRNAs in APP swe/PSΔE9 transgenic mice].
Ding Y; Tian M; Liu J; Deng Y; Li W; Feng X; Hou D
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1280-3. PubMed ID: 22985563
[TBL] [Abstract][Full Text] [Related]
24. Differential microRNA expression analyses across two brain regions in Alzheimer's disease.
Dobricic V; Schilling M; Schulz J; Zhu LS; Zhou CW; Fuß J; Franzenburg S; Zhu LQ; Parkkinen L; Lill CM; Bertram L
Transl Psychiatry; 2022 Aug; 12(1):352. PubMed ID: 36038535
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells.
Tang W; Guo J; Gu R; Lei B; Ding X; Ma J; Xu G
Mol Vis; 2020; 26():64-75. PubMed ID: 32165827
[TBL] [Abstract][Full Text] [Related]
26. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
[TBL] [Abstract][Full Text] [Related]
27. Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease.
Arena A; Iyer AM; Milenkovic I; Kovacs GG; Ferrer I; Perluigi M; Aronica E
Curr Alzheimer Res; 2017; 14(12):1305-1317. PubMed ID: 28720071
[TBL] [Abstract][Full Text] [Related]
28. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
[TBL] [Abstract][Full Text] [Related]
29. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
[TBL] [Abstract][Full Text] [Related]
30. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
Nagaraj S; Zoltowska KM; Laskowska-Kaszub K; Wojda U
Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
[TBL] [Abstract][Full Text] [Related]
31. Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes.
Kriegel AJ; Baker MA; Liu Y; Liu P; Cowley AW; Liang M
Hypertension; 2015 Oct; 66(4):793-9. PubMed ID: 26283043
[TBL] [Abstract][Full Text] [Related]
32. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
33. Identification of a lncRNA/circRNA-miRNA-mRNA ceRNA Network in Alzheimer's Disease.
Su L; Zhang Y; Wang Y; Wei H
J Integr Neurosci; 2023 Oct; 22(6):136. PubMed ID: 38176923
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
[TBL] [Abstract][Full Text] [Related]
35. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease.
Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP
FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233
[TBL] [Abstract][Full Text] [Related]
36. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
37. Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress.
Hong J; Hong SG; Lee J; Park JY; Eriksen JL; Rooney BV; Park Y
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1559-H1569. PubMed ID: 32383993
[TBL] [Abstract][Full Text] [Related]
38. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
[TBL] [Abstract][Full Text] [Related]
39. CircCRIM1 Ameliorates Endothelial Cell Angiogenesis in Aging through the miR-455-3p/Twist1/VEGFR2 Signaling Axis.
Zhao L; Chen R; Qiu J; Huang Y; Lian C; Zhu X; Cui J; Wang S; Wang S; Hu Z; Wang J
Oxid Med Cell Longev; 2022; 2022():2062885. PubMed ID: 36254231
[TBL] [Abstract][Full Text] [Related]
40. Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice.
Fernandes A; Caldeira C; Cunha C; Ferreiro E; Vaz AR; Brites D
Cells; 2022 Jan; 11(1):. PubMed ID: 35011699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
